Logo image of ADN.CA

ACADIAN TIMBER CORP (ADN.CA) Stock Fundamental Analysis

TSX:ADN - Toronto Stock Exchange - CA0042721005 - Common Stock - Currency: CAD

18.17  +0.06 (+0.33%)

Fundamental Rating

5

Overall ADN gets a fundamental rating of 5 out of 10. We evaluated ADN against 12 industry peers in the Paper & Forest Products industry. While ADN has a great profitability rating, there are quite some concerns on its financial health. ADN has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year ADN was profitable.
In the past year ADN had a positive cash flow from operations.
In the past 5 years ADN has always been profitable.
Each year in the past 5 years ADN had a positive operating cash flow.
ADN.CA Yearly Net Income VS EBIT VS OCF VS FCFADN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

1.2 Ratios

With an excellent Return On Assets value of 3.19%, ADN belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
ADN has a better Return On Equity (5.70%) than 91.67% of its industry peers.
The Return On Invested Capital of ADN (2.48%) is better than 66.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ADN is in line with the industry average of 3.92%.
Industry RankSector Rank
ROA 3.19%
ROE 5.7%
ROIC 2.48%
ROA(3y)5.08%
ROA(5y)4.63%
ROE(3y)9.11%
ROE(5y)8.26%
ROIC(3y)2.69%
ROIC(5y)2.83%
ADN.CA Yearly ROA, ROE, ROICADN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

Looking at the Profit Margin, with a value of 17.26%, ADN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Profit Margin of ADN has grown nicely.
The Operating Margin of ADN (18.25%) is better than 100.00% of its industry peers.
ADN's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 31.36%, ADN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
ADN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.25%
PM (TTM) 17.26%
GM 31.36%
OM growth 3Y-3.67%
OM growth 5Y-1.71%
PM growth 3Y-1.44%
PM growth 5Y1.58%
GM growth 3Y0.77%
GM growth 5Y0.08%
ADN.CA Yearly Profit, Operating, Gross MarginsADN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ADN is destroying value.
The number of shares outstanding for ADN has been increased compared to 1 year ago.
ADN has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ADN has a worse debt to assets ratio.
ADN.CA Yearly Shares OutstandingADN.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ADN.CA Yearly Total Debt VS Total AssetsADN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

ADN has an Altman-Z score of 1.29. This is a bad value and indicates that ADN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.29, ADN is doing worse than 66.67% of the companies in the same industry.
The Debt to FCF ratio of ADN is 4.85, which is a neutral value as it means it would take ADN, 4.85 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 4.85, ADN is doing good in the industry, outperforming 66.67% of the companies in the same industry.
ADN has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
ADN has a Debt to Equity ratio of 0.34. This is comparable to the rest of the industry: ADN outperforms 58.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 4.85
Altman-Z 1.29
ROIC/WACC0.38
WACC6.49%
ADN.CA Yearly LT Debt VS Equity VS FCFADN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.16 indicates that ADN should not have too much problems paying its short term obligations.
ADN has a Current ratio of 1.16. This is amonst the worse of the industry: ADN underperforms 83.33% of its industry peers.
ADN has a Quick Ratio of 1.16. This is a bad value and indicates that ADN is not financially healthy enough and could expect problems in meeting its short term obligations.
ADN has a Quick ratio (0.94) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 0.94
ADN.CA Yearly Current Assets VS Current LiabilitesADN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2

3. Growth

3.1 Past

The earnings per share for ADN have decreased strongly by -35.63% in the last year.
Measured over the past years, ADN shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.80% on average per year.
The Revenue has grown by 12.30% in the past year. This is quite good.
ADN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.05% yearly.
EPS 1Y (TTM)-35.63%
EPS 3Y4.63%
EPS 5Y-9.8%
EPS Q2Q%-40%
Revenue 1Y (TTM)12.3%
Revenue growth 3Y6.68%
Revenue growth 5Y3.05%
Sales Q2Q%-13.8%

3.2 Future

ADN is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.83% yearly.
Based on estimates for the next years, ADN will show a decrease in Revenue. The Revenue will decrease by -3.01% on average per year.
EPS Next Y-15.83%
EPS Next 2Y-8.92%
EPS Next 3Y-5.48%
EPS Next 5Y-4.83%
Revenue Next Year-4.47%
Revenue Next 2Y-3.01%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ADN.CA Yearly Revenue VS EstimatesADN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
ADN.CA Yearly EPS VS EstimatesADN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 16.22, which indicates a correct valuation of ADN.
Compared to the rest of the industry, the Price/Earnings ratio of ADN indicates a rather cheap valuation: ADN is cheaper than 83.33% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.69, ADN is valued a bit cheaper.
The Price/Forward Earnings ratio is 17.38, which indicates a rather expensive current valuation of ADN.
ADN's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 37.36, ADN is valued rather cheaply.
Industry RankSector Rank
PE 16.22
Fwd PE 17.38
ADN.CA Price Earnings VS Forward Price EarningsADN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

ADN's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ADN is more expensive than 75.00% of the companies in the same industry.
66.67% of the companies in the same industry are more expensive than ADN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 13.67
EV/EBITDA 20.73
ADN.CA Per share dataADN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The excellent profitability rating of ADN may justify a higher PE ratio.
A cheap valuation may be justified as ADN's earnings are expected to decrease with -5.48% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.92%
EPS Next 3Y-5.48%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.46%, ADN is a good candidate for dividend investing.
ADN's Dividend Yield is rather good when compared to the industry average which is at 5.79. ADN pays more dividend than 91.67% of the companies in the same industry.
ADN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 6.46%

5.2 History

The dividend of ADN decreases each year by -10.56%.
ADN has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of ADN decreased recently.
Dividend Growth(5Y)-10.56%
Div Incr Years1
Div Non Decr Years1
ADN.CA Yearly Dividends per shareADN.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

53.45% of the earnings are spent on dividend by ADN. This is a bit on the high side, but may be sustainable.
The Dividend Rate of ADN has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP53.45%
EPS Next 2Y-8.92%
EPS Next 3Y-5.48%
ADN.CA Yearly Income VS Free CF VS DividendADN.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M
ADN.CA Dividend Payout.ADN.CA Dividend Payout, showing the Payout Ratio.ADN.CA Dividend Payout.PayoutRetained Earnings

ACADIAN TIMBER CORP

TSX:ADN (7/23/2025, 7:00:00 PM)

18.17

+0.06 (+0.33%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)07-23 2025-07-23
Inst Owners9.34%
Inst Owner ChangeN/A
Ins Owners0.66%
Ins Owner ChangeN/A
Market Cap326.70M
Analysts76.67
Price Target19.38 (6.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.46%
Yearly Dividend0.66
Dividend Growth(5Y)-10.56%
DP53.45%
Div Incr Years1
Div Non Decr Years1
Ex-Date06-30 2025-06-30 (0.29)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)96.99%
Min EPS beat(2)29.95%
Max EPS beat(2)164.03%
EPS beat(4)2
Avg EPS beat(4)35.71%
Min EPS beat(4)-43.07%
Max EPS beat(4)164.03%
EPS beat(8)6
Avg EPS beat(8)140.24%
EPS beat(12)10
Avg EPS beat(12)184.65%
EPS beat(16)12
Avg EPS beat(16)136.59%
Revenue beat(2)1
Avg Revenue beat(2)4.73%
Min Revenue beat(2)-2.31%
Max Revenue beat(2)11.76%
Revenue beat(4)2
Avg Revenue beat(4)10.02%
Min Revenue beat(4)-9.02%
Max Revenue beat(4)39.67%
Revenue beat(8)3
Avg Revenue beat(8)5.83%
Revenue beat(12)4
Avg Revenue beat(12)0.39%
Revenue beat(16)7
Avg Revenue beat(16)1.41%
PT rev (1m)0%
PT rev (3m)-7.32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-35.9%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-17.67%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 16.22
Fwd PE 17.38
P/S 2.91
P/FCF 13.67
P/OCF 11.72
P/B 0.96
P/tB 0.98
EV/EBITDA 20.73
EPS(TTM)1.12
EY6.16%
EPS(NY)1.05
Fwd EY5.75%
FCF(TTM)1.33
FCFY7.32%
OCF(TTM)1.55
OCFY8.54%
SpS6.24
BVpS18.89
TBVpS18.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.19%
ROE 5.7%
ROCE 3.45%
ROIC 2.48%
ROICexc 2.5%
ROICexgc 2.53%
OM 18.25%
PM (TTM) 17.26%
GM 31.36%
FCFM 21.3%
ROA(3y)5.08%
ROA(5y)4.63%
ROE(3y)9.11%
ROE(5y)8.26%
ROIC(3y)2.69%
ROIC(5y)2.83%
ROICexc(3y)2.73%
ROICexc(5y)2.88%
ROICexgc(3y)2.76%
ROICexgc(5y)2.92%
ROCE(3y)3.75%
ROCE(5y)3.95%
ROICexcg growth 3Y0.45%
ROICexcg growth 5Y-5.14%
ROICexc growth 3Y0.47%
ROICexc growth 5Y-5.06%
OM growth 3Y-3.67%
OM growth 5Y-1.71%
PM growth 3Y-1.44%
PM growth 5Y1.58%
GM growth 3Y0.77%
GM growth 5Y0.08%
F-Score5
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 4.85
Debt/EBITDA 5.46
Cap/Depr 611.37%
Cap/Sales 3.55%
Interest Coverage 6.08
Cash Conversion 131.95%
Profit Quality 123.4%
Current Ratio 1.16
Quick Ratio 0.94
Altman-Z 1.29
F-Score5
WACC6.49%
ROIC/WACC0.38
Cap/Depr(3y)780.67%
Cap/Depr(5y)518.79%
Cap/Sales(3y)3.37%
Cap/Sales(5y)2.17%
Profit Quality(3y)61.15%
Profit Quality(5y)72.04%
High Growth Momentum
Growth
EPS 1Y (TTM)-35.63%
EPS 3Y4.63%
EPS 5Y-9.8%
EPS Q2Q%-40%
EPS Next Y-15.83%
EPS Next 2Y-8.92%
EPS Next 3Y-5.48%
EPS Next 5Y-4.83%
Revenue 1Y (TTM)12.3%
Revenue growth 3Y6.68%
Revenue growth 5Y3.05%
Sales Q2Q%-13.8%
Revenue Next Year-4.47%
Revenue Next 2Y-3.01%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.3%
EBIT growth 3Y2.77%
EBIT growth 5Y1.28%
EBIT Next Year14.35%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y111.36%
FCF growth 3Y13.98%
FCF growth 5YN/A
OCF growth 1Y139.15%
OCF growth 3Y28.01%
OCF growth 5YN/A